20 Years ECA Academy

From 6-7 June 2019 in Heidelberg, Germany

Join us and celebrate the 20 years anniversary of ECA in Heidelberg at the 8th European GMP Conference
- Meet speakers from US FDA, EU GMP Inspectorates and Pharmaceutical Industry to hear the latest GMP Trends
- Receive the latest ECA Guidance Documents at no costs!

Find out more

Pharma Congress 2019

From 9-10 April 2019 in Düsseldorf, Germany
- More than 60 Speakers from pharmaceutical companies and GMP Inspectorates
- Case Studies from Novartis, Roche, Boehringer Ingelheim, Sanofi, Bayer, Pfizer and many more
- 3 GMP/FDA Conferences – create your own agenda!

Find out more

Acknowledged GMP/GDP Certification

Highly qualified personnel is crucial in the pharmaceutical industry. The ECA Certification scheme with 14 continuous education programmes trains you adequately.

Read more

GMP/GDP Training Matrix

GMP/GDP Training Matrix

Are you looking for certain GMP/GDP Training Courses? The GMP/GDP Matrix will help you find your training course.

Find out more

ECA – Your GMP/GDP Information Source

With news, trainings and conferences, a comprehensive guidelines database, publications and more the ECA is the leading European training and information services provider in the GMP and GDP environment.

Read more

Latest GMP News

Mar 21

Brexit: GDP Updates for Import Activities and Air Freight ...

MHRA has published new Guidance for import and air freight activities. One is introducing a new function, the Responsible Person (import) - RPi.

More

Mar 21

Hard Brexit: Liability Risk for Carriers ...

In the case of a "Hard Brexit", delays in import and export are to be expected. This will affect contracts and liability.

More

Mar 21

Delivery of not ordered goods - what to do? ...

A wholesaler receives a delivery of a medicinal product. However, the order was not placed. What should be done?

More

Mar 21

FDA´s Pilot Program for Established Conditions ...

The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) announced a new pilot program where sponsors can propose established conditions (ECs) as part of an original new drug application (NDA), abbreviated new drug application (ANDA), biologics license application (BLA) or as a prior approval supplement (PAS).

More

Mar 21

Is the review of the Audit Trail required in Clinical trials? ...

The MHRA recently provided guidance on Data Integrity in clinical trials. Is the review of the audit trail required?

More

Mar 21

Short Format Development Safety Update Report ...

Not all trials are the same in terms of risk. Therefore, the MHRA proposesd a simpler and shorter form in lieu of a full Development Safety Update Report, giving a significant time saving.

More

GMP Newsletter

Sign up for the free of charge newsletters.

Sign up now!

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK